Besides inflammation, other mechanisms can modulate the effects of obesity in cancer patients, including alterations of insulin-like growth factor pathways, induction of hypoxia and HIF-1α signaling, and modulation of microbiota (59). This evidence concerns the gene HIF1A and obesity due to melanocortin 4 receptor deficiency.